199 related articles for article (PubMed ID: 32290440)
21. Telomere biology of pediatric cancer.
Tabori U; Dome JS
Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and treatment of ALT tumors: is Trabectedin a new therapeutic option?
Pompili L; Leonetti C; Biroccio A; Salvati E
J Exp Clin Cancer Res; 2017 Dec; 36(1):189. PubMed ID: 29273061
[TBL] [Abstract][Full Text] [Related]
23. Telomere lengthening in telomerase-negative cells: the ends are coming together.
Scheel C; Poremba C
Virchows Arch; 2002 Jun; 440(6):573-82. PubMed ID: 12070595
[TBL] [Abstract][Full Text] [Related]
24. Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas.
Scheel C; Schaefer KL; Jauch A; Keller M; Wai D; Brinkschmidt C; van Valen F; Boecker W; Dockhorn-Dworniczak B; Poremba C
Oncogene; 2001 Jun; 20(29):3835-44. PubMed ID: 11439347
[TBL] [Abstract][Full Text] [Related]
25. Alternative lengthening of telomeres, telomerase, and cancer.
Reddel RR
Cancer Lett; 2003 May; 194(2):155-62. PubMed ID: 12757973
[TBL] [Abstract][Full Text] [Related]
26. Telomere-maintenance mechanisms in soft-tissue malignant fibrous histiocytomas.
Matsuo T; Shay JW; Wright WE; Hiyama E; Shimose S; Kubo T; Sugita T; Yasunaga Y; Ochi M
J Bone Joint Surg Am; 2009 Apr; 91(4):928-37. PubMed ID: 19339578
[TBL] [Abstract][Full Text] [Related]
27. DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta.
Novakovic B; Napier CE; Vryer R; Dimitriadis E; Manuelpillai U; Sharkey A; Craig JM; Reddel RR; Saffery R
Mol Hum Reprod; 2016 Nov; 22(11):791-799. PubMed ID: 27604461
[TBL] [Abstract][Full Text] [Related]
28. The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit.
Bryan TM; Marusic L; Bacchetti S; Namba M; Reddel RR
Hum Mol Genet; 1997 Jun; 6(6):921-6. PubMed ID: 9175740
[TBL] [Abstract][Full Text] [Related]
29. Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma.
Ohali A; Avigad S; Naumov I; Goshen Y; Ash S; Yaniv I
Genes Chromosomes Cancer; 2008 Nov; 47(11):965-70. PubMed ID: 18663749
[TBL] [Abstract][Full Text] [Related]
30. Targeting ALT: the role of alternative lengthening of telomeres in pathogenesis and prevention of cancer.
Bollmann FM
Cancer Treat Rev; 2007 Dec; 33(8):704-9. PubMed ID: 17933469
[TBL] [Abstract][Full Text] [Related]
31. Pan-Cancer Analysis of Alternative Lengthening of Telomere Activity.
Sung JY; Lim HW; Joung JG; Park WY
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32784588
[TBL] [Abstract][Full Text] [Related]
32. Alternative lengthening of telomeres: from molecular mechanisms to therapeutic outlooks.
Zhang JM; Zou L
Cell Biosci; 2020; 10():30. PubMed ID: 32175073
[TBL] [Abstract][Full Text] [Related]
33. Telomeres and telomerase in sarcomas.
Matsuo T; Shimose S; Kubo T; Fujimori J; Yasunaga Y; Ochi M
Anticancer Res; 2009 Oct; 29(10):3833-6. PubMed ID: 19846916
[TBL] [Abstract][Full Text] [Related]
34. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
[TBL] [Abstract][Full Text] [Related]
35. Life and cancer without telomerase: ALT and other strategies for making sure ends (don't) meet.
Apte MS; Cooper JP
Crit Rev Biochem Mol Biol; 2017 Feb; 52(1):57-73. PubMed ID: 27892716
[TBL] [Abstract][Full Text] [Related]
36. Increased alternative lengthening of telomere phenotypes of telomerase-negative immortal cells upon trichostatin--a treatment.
Jung AR; Yoo JE; Shim YH; Choi YN; Jeung HC; Chung HC; Rha SY; Oh BK
Anticancer Res; 2013 Mar; 33(3):821-9. PubMed ID: 23482750
[TBL] [Abstract][Full Text] [Related]
37. Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma.
Villa R; Daidone MG; Motta R; Venturini L; De Marco C; Vannelli A; Kusamura S; Baratti D; Deraco M; Costa A; Reddel RR; Zaffaroni N
Clin Cancer Res; 2008 Jul; 14(13):4134-40. PubMed ID: 18593991
[TBL] [Abstract][Full Text] [Related]
38. Alternative lengthening of telomeres can be maintained by preferential elongation of lagging strands.
Min J; Wright WE; Shay JW
Nucleic Acids Res; 2017 Mar; 45(5):2615-2628. PubMed ID: 28082393
[TBL] [Abstract][Full Text] [Related]
39. Telomere maintenance and tumorigenesis: an "ALT"ernative road.
Stewart SA
Curr Mol Med; 2005 Mar; 5(2):253-7. PubMed ID: 15974880
[TBL] [Abstract][Full Text] [Related]
40. Alternative lengthening of telomeres in the human adrenocortical carcinoma cell line H295R.
Fujiwara M; Kamma H; Wu W; Yano Y; Homma S; Satoh H
Int J Oncol; 2006 Aug; 29(2):445-51. PubMed ID: 16820888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
